|
|
COVID-19: TCTMD’s Daily Dispatch
|
COVID-19 TCTMD WEBCAST SERIES
|
|
Friday, May 29
A group of scientists is asking for the numbers to be made public and externally validated. A Lancet study investigator responds. |
|
|
Friday, May 29
Physicians latched quickly onto hopes that antimalarial drugs could help, but weren’t swayed by ACE inhibitor/ARB theories. |
|
|
Monday, May 26
Two large analyses reinforce the view that the antimalarial medications raise the risk of death and arrhythmia. |
|
|
Monday, May 26
COVID-19 Autopsies Put Endothelial Damage, Angiogenesis in the Spotlight |
|
|
Monday, May 25
There’s more to learn about the mechanisms of stroke in COVID-19 patients, as well as the impact of stay-at-home orders. |
|
|
Friday, May 22
In China, the virus was largely contracted from within the hospital, while community acquisition was likely in Holland. |
|
|
Friday, May 22
As data come in from big hospital networks and across countries, physicians are urging health administrators to learn the lessons. |
|
|
Friday, May 22
About one-third of polled program directors and current fellows said training should somehow be extended. |
|
|
Thursday, May 21
Physicians are still learning about the newly identified multisystem inflammatory syndrome in children (MIS-C). |
|
|
Thursday, May 21
It remains to be seen whether the drugs increase the likelihood of infection or whether they may in fact be helpful treatments. |
|
|
Wednesday, May 20 | FEATURE Hydroxychloroquine: No Help, Clear Harm in COVID-19 RCT and Cohort StudiesPresident Trump says he’s taking it daily, but three new studies and an ACP warning say hydroxychloroquine is of little benefit. |
|
|
Wednesday, May 20
Compared with survivors, those who died were more likely to have elevated troponins as well as comorbidities. |
|
|
Wednesday, May 20 | FEATURE Cardiology After COVID-19: Physicians Predict Lasting ChangeA new era for telemedicine, rebuilding patient trust, and an increase in efficiency of care were common themes. |
|
|
Tuesday, May 19
The prospective study from the US hot spot also shows a high rate of multiple organ failure, including severe kidney disease. |
|
|
Thursday, May 14
In Bergamo province, investigators report a 30-fold increase in severe Kawasaki, diagnosed according to accepted criteria. |
|
|
Wednesday, May 13
Schools, teams, competitive athletes, and dedicated amateurs are starting to ask clinicians how they can get back in the game. |
|
|
Tuesday, May 12 | FEATURE Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 WanesWorking off the backlog of elective CV cases put on hold for the last 8 weeks will be more of a marathon than a sprint, say docs. |
|
|
Monday, May 11
The data support the idea that some patients may need anticoagulation to prevent pulmonary embolism. |
|
|
Friday, May 8 | FEATURE Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s CulpabilityIn some cases, large strokes are the first presentation of COVID-19 in younger patients, but numbers are lacking and uncertainty abounds. |
|
|
Friday, May 8
Some physicians report an uptick in cases, but the size of the problem needs more study. |
|
|
Wednesday, May 6
Mount Sinai physicians found lower mortality with systemic anticoagulation and plan to dig deeper. |
|
|
Wednesday, May 6
Two pediatric cardiologists are convinced this is “something to be aware of,” with one urging echocardiographic follow-up. |
|
|
Tuesday, May 5
RAAS inhibitors also do lead not to more-severe COVID-19, providing reassurances for patients treated with the drugs. |
|
|
Tuesday, May 5
The finding supports anecdotal reports of STEMI mimics but not a role for fibrinolysis during the pandemic, one researcher says. |
|
|
Monday, May 4
RVLS outdid other echo parameters in Wuhan-based patients but needs further study, particularly in other populations. |
|
|
Friday, May 1
Investigators believe theirs are the first published data showing high numbers of at-home cardiac arrests amid the pandemic. |
|
|
Wednesday, April 29
The IV drug has a “clear-cut, significant, positive effect on diminishing the time to recovery,” says Anthony Fauci. |
|
|
Wednesday, April 29
A French series is putting PE in the spotlight, but the optimal anticoagulation strategy remains unknown. |
|
|
Wednesday, April 29 | FEATURE Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital AvoidanceGlobally, cardiologists are seeing VSDs, papillary ruptures, and other complications rarely seen in the primary PCI era. |
|
|
Tuesday, April 28
When telemetry beds are scarce, these monitors rapidly detect issues and also minimize contact with infectious patients. |
|
|
Friday, April 24
Social isolation doesn’t just mean Netflix on the couch, say prevention experts, who stress the importance of daily exercise. |
|
|
Friday, April 24
Two retrospective studies from China found no link to higher mortality, with one even suggesting lower death risk. |
|
|
Thursday, April 23 | FEATURE Hopes High for Anti-inflammatories to Combat COVID-19 Immune System StormsHow the immune response tips so radically off-balance is unclear, but research, some drawing on recent CVD trials, ploughs on. |
|
|
Wednesday, April 22
A new review explores the higher risk of thrombotic disease with this coronavirus, how to prevent and treat it, plus research gaps. |
|
|
Tuesday, April 21 | FEATURE Obesity and COVID-19: Theories and Blame Fill the Scientific VoidObesity is the latest theory du jour for why some SARS-CoV-2 infections take a deadlier course, particularly in the young. |
|
|
Monday, April 20
Better testing and culturally targeted PSAs are needed in the short term; on the other side, societal fixes will be critical. |
|
|
Friday, April 17 | FEATURE As COVID-19 Spreads, US Cath Labs Ponder Fibrinolytics for STEMIBusiness as usual may not be possible, and overwhelmed hospitals may consider lytic-based pathways, a group says. |
|
|
Friday, April 17 | FEATURE Could Robotic PCI Play a Protective Role in Pandemics?Some say COVID-19 might pave the way for more robotic procedures, but proof they cut disease transmission is lacking. |
|
|
Thursday, April 16 | FEATURE Thanks to COVID-19, Cardiology Fellows Gain Unexpected Skills but Risk Losing OthersTrading catheters for central lines, many fellows are stepping into roles they’d never imagined, while programs adapt. |
|
|
Wednesday, April 15
Although the majority did not require hospitalization, severe disease and death were reported across age groups. |
|
|
Tuesday, April 14
Eight societies came together to offer tips on how healthcare providers can protect themselves while helping their patients. |
|
|
Tuesday, April 14 | FEATURE An Age/Old Dilemma? Pulling Senior Cardiologists From the Front During COVID-19Some US hospitals have asked doctors over a certain age to work from home, but surge situations may mean all hands on deck. |
|
|
Monday, April 13
Which TAVR can be deferred, which MV should be repaired? Advice from ACC, SCAI, and the heart of the US pandemic. |
|
|
Monday, April 13
Their suggestions include an increased use of POCUS, greater scrutiny of orders, and a hiatus for hands-on training. |
|
|
Friday, April 10
Numbers from nine US hospitals largely echo the drop seen in Spain. Understanding the consequences is key, experts say. |
|
|
Friday, April 10
Expert's say there's no better time than now to keep preventative CV care going and forge a new path for outpatient cardiac rehab. |
|
|
Friday, April 10
Half of patients who died during a 10-day stretch in January had hypertension. |
|
|
Tuesday, April 7 | FEATURE ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19RCTs are paused or slowing to a trickle. Researchers predict data gaps, less funding, and new priorities when the pandemic ends |
|
|
Friday, April 3
Hydroxychloroquine, chloroquine, and azithromycin all prolong QT interval. The next step is studying if their benefit exceeds risk. |
|
|
Thursday, April 2 | FEATURE The Mystery of the Missing STEMIs During the COVID-19 PandemicFear of infection is likely the biggest driver, but as other theories circulate, cardiologists are bracing for the fallout. |
|
|
Friday, March 27 | FEATURE Mixed Messages on COVID-19 Masks: Science Falls Short As Deaths MountDifferent hospital policies as to who should wear a mask—and when—pit a shaky evidence base against a supply chain shortage. |
 |
Thursday, March 26
The new, detailed guidance does not amount to “hard and fast rules.” SCAI says hospitals need to make case-by-case decisions |
|
|
Thursday, March 26
Experts stress there is not enough evidence to suggest these medications can worsen COVID-19 morbidity and mortality. |
|
|
Thursday, March 26
Wuhan researchers have published details on 416 hospitalized patients, but treatment pathways remain unclear. |
|
|
Wednesday, March 25
The experience of Chinese physicians is leading the way for others around the world as the pandemic explodes in the US. |
|
|
Tuesday, March 24 | FEATURE Telehealth Offers a Lifeline for Cardiology Patients During the COVID-19 PandemicFrom FaceTime to old-fashioned telephone visits, healthcare workers are turning to virtual means to conduct clinical care. |
 |
Friday, March 20 | FEATURE ‘Terrified’ Healthcare Workers Fear Lack of Protection Against COVID-19“You wouldn’t send a soldier into war without a gun or body armor,” one doctor says. Hard-hit areas offer some tips. |
|
|
Wednesday, March 18
Be prepared, experts urge. Much is still unknown about how the novel coronavirus will affect day-to-day and emergency CVD care. |
|
|
Tuesday, March 17
(UPDATED) More research is needed, but for now, there’s no evidence that background use of the agents harms or helps in COVID-19. |
 |
Monday, March 9
Within hours of the ACC’s announcement, the European Heart Rhythm Association 2020 also announced their meeting was off. |
|
|
Wednesday, March 4
It’s a wise move, Mamas Mamas says, both for the health of the attendees and for the patients they care for back home. |
|
|
Thursday, February 13
One piece of advice is to not overlook classic symptoms and presentation of acute MI in the context of the COVID-19 virus. |
|
|
Tuesday, February 4
China Interventional Therapeutics 2020, slated for April, has been canceled, but little impact is anticipated for other conferences. |
|
|
On Record: Missing STEMIs Amid COVID-19Shelley Wood hears from Gennaro Sardella, Ghada Mikhail, and Javier Escaned about STEMI patients delayed by COVID-19 and those that didn't come at all. |
|
|
The Impact of Social Isolation and Outcomes in the COVID-19 Era: Lessons from EU PoliciesMichael Borger, Juan Granada, Mamas Mamas, Thomas Modine, Goran Olivecrona, and Holger Thiele discuss the impact of social isolation and outcomes in the EU during the COVID-19 era. |
|
|
Restructuring Structural Heart Practice During COVID-19Christine Chung, Susheel Kodali, Jacob Mishell, Tamim Nazif, and Mark Reisman discuss COVID-19's impact on structural heart programs: triaging patients, ensuring safety, and how to restart a practice that has been put on hold. |
|
|
They Had COVID-19: Physician Stories, On RecordShelley Wood hears about symptoms, self-management, and takeaways from Gennaro Giustino, Isaac George, Azeem Latib, and Jordan Safirstein. |
|
|
Impact of COVID-19 on Interventional and Surgical ProceduresHow has the cath lab adapted to perform interventional and surgical procedures in high-risk or COVID19+ patients? This three part webcast addresses current challenges and recommendations with perspectives from the Chinese Society of Cardiology. |
|
|
COVID-19 and Fellows Implication on Clinical Training and SafetyMamas Mamas, Jay Mohan, Purvi Parwani, Nosheen Reza, Juan Granada, Sarah Hudson, Sahil Parikh, Martha Gulati, & Danielle Belardo discuss the impact of COVID-19 on cardiology fellowship programs from redeployment to adapting education and training. |
|
|
COVID-19 Lessons from ChinaDrs. Juan Granada, Martha Gulati, Ajay Kirtane, Mamas Mamas, and Christ White discuss lessons learned and applicability from China’s approach to managing COVID-19. |
|
|
Hospital Preparedness, Current Management Protocols, and Pulmonary Care During COVID-19Juan Granada, Azeem Latib, Mamas Mamas, and Federico Pappalardo discuss hospital preparedness and management protocols as well as pulmonary care for the non-pulmonary specialist in this special edition webcast on COVID-19. |
|
|
Cardiac Injury in COVID-19 PatientsRoxana Mehran, Ajay Kirtane, and Gennaro Giustino discuss the latest data on cardiac injury and COVID-19. |
 |
Top Stories in Cardiology: May 2020This month, Barbara Casadei describes how the UK is emerging from COVID-19. |
|
|
Rox Heart Radio: From the Front With Amreen DinaniAs part of a special series on female physicians, Roxana Mehran speaks with Amreen Dinani about her experiences with COVID-19 in New York City. |
|
|
Rox Heart Radio: From the Front With Ladan GolestanehRoxana Mehran talks with Ladan Golestaneh. caring for patients in the Bronx. |
|
|
Rox Heart Radio: From the Front With Leila HosseinianToday, Roxana Mehran hears COVID-19 news from Leila Hosseinian, based in Chicago, IL. |
|
Top Stories in Cardiology: April 2020In the COVID-19 era, older and younger physicians, telehealth, RCTs, obesity, and inflammation |
|
|
Rox Heart Radio: From the Front With Miguel MartilloToday, Roxana Mehran hears from Miguel Martillo in New York City |
|
|
Rox Heart Radio: From the Front With Laxmi Mehta and Benjamin SalterIn this episode, Roxana Mehran takes on physician wellness in COVID-19 with Laxmi Mehta and Benjamin Salter. |
|
|
Rox Heart Radio: From the Front With George Dangas and Ajay KirtaneToday, Roxana Mehran discusses PPE in COVID-19 with George Dangas and Ajay Kirtane. |
|
|
Rox Heart Radio: From the FrontRoxana Mehran speaks with Giulio Stefanini and Gennaro Giustino about the latest developments related to COVID-19. |
|
Top Stories in Cardiology: March 2020This month features an in-depth conversation on COVID-19 with Alaide Chieffo, MD. |
|
|
TCTMD’s Top 10 Most Popular Stories for April 2020Missing MIs, inflammation, thrombosis, safe echo, junior and senior physicians, clinical trials, and more, all related to COVID-19. |
 |
COVID-19 and the Heart: Insights From the Front LinesAs COVID-19 cases go global, a picture is emerging as to its CV impact and how cardiologists in hard-hit regions are coping. |
 |
COVID-19 Begs the Question: If Medical Meetings Go Virtual, What Do We Gain and Lose?The coronavirus has led to cancelled meetings and hospitals barring physician travel, offering a glimpse of the future of medical education. |
This program is sponsored by the Cardiovascular Research Foundation and supported through an unrestricted grant from Edwards Lifesciences. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from commercial supporters.